Dr Ben Bikman talks about the use and effects of GLP-1 Agonists (Semaglutide – Ozempic and Wegovy)
In this episode, I chat with Dr Benjamin Bikman about GLP-1 agonists, a class of drugs used for weight loss and diabetes management. These are more commonly known as Semaglutide - Ozempic and Wegovy. We discuss the role of GLP-1 in metabolism, the effects of GLP-1 agonists on weight loss and insulin sensitivity, and the potential side effects and limitations of these drugs.
Please login below or sign up to access the rest of this article.